300751:SZSESuzhou Maxwell Technologies Co., Ltd. Class A Analysis
Data as of 2026-03-16 - not real-time
CN¥250.70
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
Suzhou Maxwell Technologies is trading above its 20‑day SMA and comfortably above the 50‑day SMA, signaling a short‑term bullish momentum despite a bearish MACD histogram and a decreasing volume trend. Technical indicators suggest the price is holding near a key support level while the 30‑day volatility remains elevated, implying price swings could be pronounced. Fundamentally, the company carries an extremely high trailing PE relative to its industry average and a forward PE still well above peers, pointing to significant overvaluation. The balance sheet shows a high debt‑to‑equity ratio and negative operating and free cash flow, raising concerns about cash sustainability, while the modest dividend yield and payout ratio do not offset the cash‑flow weakness.
In the medium term, revenue contraction and margin pressures temper optimism, yet the firm’s position in the growing solar‑cell equipment niche offers a potential catalyst if market demand accelerates. Investors should weigh the strong technical support against the financial strain and lofty valuation before deciding on entry or exit.
In the medium term, revenue contraction and margin pressures temper optimism, yet the firm’s position in the growing solar‑cell equipment niche offers a potential catalyst if market demand accelerates. Investors should weigh the strong technical support against the financial strain and lofty valuation before deciding on entry or exit.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Price above short‑term moving averages
- Bearish MACD divergence
- High short‑term volatility
Medium Term
1–3 yearsNeutral
Model confidence: 5/10
Key Factors
- Revenue decline and negative cash flow
- Exposure to solar‑equipment growth
- Persistently high valuation multiples
Long Term
> 3 yearsCautious
Model confidence: 7/10
Key Factors
- Unsustainable cash‑flow profile
- Elevated debt burden
- Valuation far above industry norms
Key Metrics & Analysis
Financial Health
Revenue Growth-31.30%
Profit Margin10.05%
P/E Ratio83.8
ROE10.57%
ROA2.06%
Debt/Equity69.67
P/B Ratio8.9
Op. Cash FlowCN¥-860177472
Free Cash FlowCN¥-1683106304
Industry P/E34.1
Technical Analysis
TrendBullish
RSI42.5
SupportCN¥245.01
ResistanceCN¥340.00
MA 20CN¥275.57
MA 50CN¥263.68
MA 200CN¥136.04
MACDBearish
VolumeDecreasing
Fear & Greed Index78.13
Valuation
Target PriceCN¥159.67
Upside/Downside-36.31%
GradeOvervalued
TypeValue
Dividend Yield0.45%
Risk Assessment
Beta0.34
Volatility72.56%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.